DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2

被引:80
作者
Holinski-Feder, E
Müller-Koch, Y
Friedl, W
Moselein, G
Keller, G
Plaschke, J
Ballhausen, W
Gross, M
Baldwin-Jedele, K
Jungck, M
Mangold, E
Vogelsang, H
Schackert, HK
Lohse, P
Murken, J
Meitinger, T
机构
[1] Univ Munich, Dept Med Genet, D-80336 Munich, Germany
[2] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany
[3] Univ Dusseldorf, Dept Surg, D-4000 Dusseldorf, Germany
[4] Tech Univ Munich, Dept Pathol, D-8000 Munich, Germany
[5] Carl Gustav Carus Univ Hosp Dresden, Dept Surg Res, Dresden, Germany
[6] Univ Erlangen Nurnberg, Dept Human Genet, Erlangen, Germany
[7] Univ Munich, Dept Gastroenterol, Munich, Germany
[8] Univ Bonn, Dept Internal Med, D-5300 Bonn, Germany
[9] Tech Univ Munich, Dept Surg, D-8000 Munich, Germany
来源
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS | 2001年 / 47卷 / 1-2期
关键词
HNPCC; hMLH1; hMSH2; mutation analysis; DHPLC;
D O I
10.1016/S0165-022X(00)00148-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Denaturing high-performance liquid chromatography (DHPLC) is an efficient method for detection of mutations involving a single or few numbers of nucleotides, and it has been successfully used for mutation detection in disease-related genes. Colorectal cancer is one of the most common cancers, and mutations in the genes for hereditary nonpolyposis colon cancer (HNPCC), hMLH1 and hMSH2, also involve mainly point mutations. Sequence analysis is supposed to be a screening method with high sensitivity; however, it is time-consuming and expensive. We therefore decided to test sensitivity and reproducibility of DHPLC for 71 sequence variants in hMLH1 and hMSH2 initially found by sequence analysis in DNA samples of German HNPCC patients. DHPLC conditions of the PCR products were based on the melting pattern of the wild-type sequence of the corresponding PCR fragments. All but one of the 71 mutations was detected using DHPLC (sensitivity of 97%). Running time pet sample averaged only 7 min, and the system is highly automated. Thus DHPLC is a rapid and sensitive method for the detection of hMLH1 and hMSH2 sequence variants. (C) 2001 published by Elsevier Science B.V.
引用
收藏
页码:21 / 32
页数:12
相关论文
共 10 条
[1]   Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA):: 47 unique mutations without correlation to clinical course [J].
Holinski-Feder, E ;
Weiss, M ;
Brandau, O ;
Jedele, KB ;
Nore, B ;
Bäckesjö, CM ;
Vihinen, M ;
Hubbard, SR ;
Belohradsky, BH ;
Smith, CIE ;
Meindl, A .
PEDIATRICS, 1998, 101 (02) :276-284
[2]   Complex genetic predisposition to cancer in an extended HNPCC family with an ancestral hMLH1 mutation [J].
Hutter, P ;
Couturier, A ;
Scott, RJ ;
Alday, P ;
DelozierBlanchet, C ;
Cachat, F ;
Antonarakis, SE ;
Joris, F ;
Gaudin, M ;
DAmato, L ;
Buerstedde, JM .
JOURNAL OF MEDICAL GENETICS, 1996, 33 (08) :636-640
[3]   Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders [J].
Liu, WO ;
Oefner, PJ ;
Qian, CP ;
Odom, RS ;
Francke, U .
GENETIC TESTING, 1997, 1 (04) :237-242
[4]   Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection [J].
O'Donovan, MC ;
Oefner, PJ ;
Roberts, SC ;
Austin, J ;
Hoogendoorn, B ;
Guy, C ;
Speight, G ;
Upadhyaya, M ;
Sommer, SS ;
McGuffin, P .
GENOMICS, 1998, 52 (01) :44-49
[5]  
OEFNER PJ, 1998, CURRENT PROTOCOLS HU
[6]   Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography [J].
Underhill, PA ;
Jin, L ;
Lin, AA ;
Mehdi, SQ ;
Jenkins, T ;
Vollrath, D ;
Davis, RW ;
CavalliSforza, LL ;
Oefner, PJ .
GENOME RESEARCH, 1997, 7 (10) :996-1005
[7]   Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations [J].
Wagner, T ;
Stoppa-Lyonnet, D ;
Fleischmann, E ;
Muhr, D ;
Pagès, S ;
Sandberg, T ;
Caux, V ;
Moeslinger, R ;
Langbauer, G ;
Borg, A ;
Oefner, P .
GENOMICS, 1999, 62 (03) :369-376
[8]   Global sequence diversity of BRCA2:: analysis of 71 breast cancer families and 95 control individuals of worldwide populations [J].
Wagner, TMU ;
Hirtenlehner, K ;
Shen, PD ;
Moeslinger, R ;
Muhr, D ;
Fleischmann, E ;
Concin, H ;
Doeller, W ;
Haid, A ;
Lang, AH ;
Mayer, P ;
Petru, E ;
Ropp, E ;
Langbauer, G ;
Kubista, E ;
Scheiner, O ;
Underhill, P ;
Mountain, J ;
Stierer, M ;
Zielinski, C ;
Oefner, P .
HUMAN MOLECULAR GENETICS, 1999, 8 (03) :413-423
[9]  
Wagner TMU, 1998, INT J CANCER, V77, P354, DOI 10.1002/(SICI)1097-0215(19980729)77:3<354::AID-IJC8>3.3.CO
[10]  
2-A